ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 162 filers reported holding ANIKA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $8,641,629 | +3.3% | 341,068 | +3.6% | 0.00% | 0.0% |
Q1 2024 | $8,361,703 | +15.7% | 329,163 | +3.2% | 0.00% | 0.0% |
Q4 2023 | $7,227,356 | +26.8% | 318,913 | +4.3% | 0.00% | 0.0% |
Q3 2023 | $5,698,885 | -25.6% | 305,860 | +3.7% | 0.00% | 0.0% |
Q2 2023 | $7,661,042 | -6.3% | 294,882 | +3.6% | 0.00% | 0.0% |
Q1 2023 | $8,175,588 | +100115.6% | 284,665 | +3.3% | 0.00% | 0.0% |
Q4 2022 | $8,158 | -99.9% | 275,622 | +4.3% | 0.00% | 0.0% |
Q3 2022 | $6,287,000 | +7.8% | 264,201 | +1.1% | 0.00% | 0.0% |
Q2 2022 | $5,832,000 | -8.4% | 261,322 | +3.1% | 0.00% | 0.0% |
Q1 2022 | $6,367,000 | -31.5% | 253,580 | -2.2% | 0.00% | 0.0% |
Q4 2021 | $9,294,000 | -15.6% | 259,393 | +0.3% | 0.00% | 0.0% |
Q3 2021 | $11,008,000 | -0.3% | 258,663 | +1.4% | 0.00% | -50.0% |
Q2 2021 | $11,041,000 | +11.7% | 255,050 | +5.2% | 0.00% | 0.0% |
Q1 2021 | $9,888,000 | +2.6% | 242,413 | +13.8% | 0.00% | 0.0% |
Q4 2020 | $9,640,000 | +30.3% | 213,001 | +1.9% | 0.00% | +100.0% |
Q3 2020 | $7,400,000 | -15.5% | 209,112 | -9.9% | 0.00% | -50.0% |
Q2 2020 | $8,758,000 | +41.7% | 232,129 | +8.6% | 0.00% | 0.0% |
Q1 2020 | $6,180,000 | -73.3% | 213,767 | -52.0% | 0.00% | 0.0% |
Q4 2019 | $23,108,000 | +90.9% | 445,708 | +102.1% | 0.00% | -33.3% |
Q3 2019 | $12,104,000 | +36.3% | 220,522 | +0.8% | 0.00% | +50.0% |
Q2 2019 | $8,883,000 | +48.6% | 218,686 | +10.6% | 0.00% | 0.0% |
Q1 2019 | $5,976,000 | -50.1% | 197,654 | -44.6% | 0.00% | 0.0% |
Q4 2018 | $11,980,000 | +65.2% | 356,468 | +107.4% | 0.00% | 0.0% |
Q3 2018 | $7,250,000 | +35.3% | 171,905 | +2.6% | 0.00% | 0.0% |
Q2 2018 | $5,359,000 | -22.7% | 167,514 | +20.1% | 0.00% | 0.0% |
Q1 2018 | $6,934,000 | -5.7% | 139,478 | +2.2% | 0.00% | 0.0% |
Q4 2017 | $7,356,000 | -4.3% | 136,468 | +2.9% | 0.00% | -33.3% |
Q3 2017 | $7,688,000 | +24.7% | 132,562 | +6.1% | 0.00% | +50.0% |
Q2 2017 | $6,163,000 | +21.2% | 124,913 | +6.7% | 0.00% | 0.0% |
Q1 2017 | $5,084,000 | -13.6% | 117,036 | -2.6% | 0.00% | -33.3% |
Q4 2016 | $5,883,000 | -0.5% | 120,164 | -2.8% | 0.00% | 0.0% |
Q3 2016 | $5,914,000 | -1.4% | 123,618 | +10.5% | 0.00% | 0.0% |
Q2 2016 | $5,999,000 | +23.5% | 111,844 | +3.0% | 0.00% | 0.0% |
Q1 2016 | $4,856,000 | +33.3% | 108,619 | +13.7% | 0.00% | +50.0% |
Q4 2015 | $3,644,000 | +22.2% | 95,493 | +1.9% | 0.00% | 0.0% |
Q3 2015 | $2,983,000 | -2.8% | 93,720 | +0.9% | 0.00% | 0.0% |
Q2 2015 | $3,068,000 | -14.2% | 92,910 | +7.0% | 0.00% | 0.0% |
Q1 2015 | $3,574,000 | +17.6% | 86,833 | +16.4% | 0.00% | 0.0% |
Q4 2014 | $3,039,000 | -0.9% | 74,615 | -10.8% | 0.00% | 0.0% |
Q3 2014 | $3,067,000 | -20.0% | 83,666 | +1.1% | 0.00% | 0.0% |
Q2 2014 | $3,832,000 | +26.7% | 82,723 | +12.4% | 0.00% | 0.0% |
Q1 2014 | $3,025,000 | -27.6% | 73,607 | -32.7% | 0.00% | -33.3% |
Q4 2013 | $4,176,000 | +221.0% | 109,436 | +101.5% | 0.00% | +200.0% |
Q3 2013 | $1,301,000 | +48.5% | 54,304 | +5.4% | 0.00% | 0.0% |
Q2 2013 | $876,000 | – | 51,522 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Portolan Capital Management | 217,105 | $10,058,000 | 2.20% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 284,393 | $13,175,000 | 0.88% |
AMI ASSET MANAGEMENT CORP | 183,494 | $8,501,000 | 0.84% |
CAPITAL MANAGEMENT CORP /VA | 49,765 | $2,306,000 | 0.74% |
TFS CAPITAL LLC | 105,839 | $4,904,000 | 0.39% |
Baltimore-Washington Financial Advisors, Inc. | 24,390 | $1,130,000 | 0.35% |
OBERWEIS ASSET MANAGEMENT INC/ | 27,600 | $1,279,000 | 0.32% |
Stephens Investment Management Group LLC | 192,650 | $8,925,000 | 0.27% |
THOMPSON SIEGEL & WALMSLEY LLC | 263,622 | $12,214,000 | 0.24% |
DIKER MANAGEMENT LLC | 21,200 | $982,000 | 0.22% |